{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:21:07Z","timestamp":1784323267182,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cvsm.2023.05.010","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T08:19:07Z","timestamp":1688717947000},"page":"1325-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypertrophic Cardiomyopathy\u2013Advances in Imaging and Diagnostic Strategies"],"prefix":"10.1016","volume":"53","author":[{"given":"Ryan","family":"Fries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cvsm.2023.05.010_bib1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2460\/javma.234.11.1398","article-title":"Prevalence of cardiomyopathy in apparently healthy cats","volume":"234","author":"Paige","year":"2009","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/jvim.12215","article-title":"Prognostic indicators in cats with hypertrophic cardiomyopathy","volume":"27","author":"Payne","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.010_bib3","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.92.9.2645","article-title":"Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease","volume":"92","author":"Fox","year":"1995","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.cvsm.2023.05.010_bib4","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/ddi386","article-title":"A\u00a0cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy","volume":"14","author":"Meurs","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygeno.2007.04.007","article-title":"A\u00a0substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy","volume":"90","author":"Meurs","year":"2007","journal-title":"Genomics"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.010_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0002-9149(93)91112-U","article-title":"Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs","volume":"72","author":"Liu","year":"1993","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.cvsm.2023.05.010_bib7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.106.638569","article-title":"Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction","volume":"115","author":"Martos","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvim.15745","article-title":"ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats","volume":"34","author":"Luis Fuentes","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvim.15122","article-title":"International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study","volume":"32","author":"Fox","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib11","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/jvim.15609","article-title":"Long-term incidence and risk of noncardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy","volume":"33","author":"Fox","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jvim.12031","article-title":"Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy","volume":"27","author":"Longeri","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2023.05.010_bib13","first-page":"S268","article-title":"Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study","volume":"17","author":"Granstr\u00f6m","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2023.05.010_bib14","first-page":"S244","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.010_bib15","series-title":"Feline cardiology","first-page":"101","article-title":"Hypertrophic cardiomyopathy","author":"C\u00f4t\u00e9","year":"2011"},{"key":"10.1016\/j.cvsm.2023.05.010_bib16","unstructured":"Reference intervals and allometric scaling of echocardiographic measurements in Bengal cats - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/26776586\/. Accessed March 14, 2023."},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.010_bib17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/jvim.14569","article-title":"Effect of Body Weight on Echocardiographic Measurements in 19,866 Pure-Bred Cats with or without Heart Disease","volume":"30","author":"H\u00e4ggstr\u00f6m","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2023.05.010_bib18","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1292\/jvms.17-0250","article-title":"Reference intervals and allometric scaling of two-dimensional echocardiographic measurements in 150 healthy cats","volume":"79","author":"Karsten","year":"2017","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.cvsm.2023.05.010_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12947-016-0072-5","article-title":"Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy","volume":"14","author":"Parato","year":"2016","journal-title":"Cardiovasc Ultrasound"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1292\/jvms.13-0241","article-title":"Feasibility of radial and circumferential strain analysis using 2D speckle tracking echocardiography in cats","volume":"77","author":"Takano","year":"2015","journal-title":"J\u00a0Vet Med Sci"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1939-1676.2010.0586.x","article-title":"Assessment of Left Ventricular Systolic Function by Strain Imaging Echocardiography in Various Stages of Feline Hypertrophic Cardiomyopathy","volume":"24","author":"Wess","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/jvim.16067","article-title":"Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy","volume":"35","author":"Fries","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12968-017-0334-x","article-title":"Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy","volume":"19","author":"Swoboda","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.010_bib25","doi-asserted-by":"crossref","first-page":"e012250","DOI":"10.1161\/JAHA.119.012250","article-title":"Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA","volume":"8","author":"Massera","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jvim.13831","article-title":"Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements","volume":"30","author":"Hezzell","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.010_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jsap.12152","article-title":"Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations","volume":"54","author":"Humm","year":"2013","journal-title":"J\u00a0Small Anim Pract"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2023.05.010_bib28","first-page":"S51","article-title":"Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats","volume":"11","author":"Fox","year":"2009","journal-title":"J\u00a0Vet Cardiol"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.010_bib29","first-page":"245","article-title":"Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation","volume":"16","author":"Machen","year":"2014","journal-title":"J\u00a0Vet Cardiol"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.010_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/1040638715588330","article-title":"Analytical validation of an immunoassay for the quantification of N-terminal pro\u2013B-type natriuretic peptide in feline blood","volume":"27","author":"Mainville","year":"2015","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1098612X15623825","article-title":"Biologic variability of N-terminal pro-brain natriuretic peptide in adult healthy cats","volume":"19","author":"Harris","year":"2017","journal-title":"J\u00a0Feline Med Surg"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib32","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1111\/jvim.15904","article-title":"ACVIM Forum On Demand Research Abstract Program","volume":"34","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","article-title":"Essential biochemistry and physiology of (NT-pro)BNP","volume":"6","author":"Hall","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the diagnosis and management of heart failure","volume":"27","author":"Castiglione","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.010_bib35","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1373\/clinchem.2004.032490","article-title":"Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides","volume":"50","author":"Ala-Kopsala","year":"2004","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2023.05.010_bib36","first-page":"S41","article-title":"Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress","volume":"11","author":"Connolly","year":"2009","journal-title":"J\u00a0Vet Cardiol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.010_bib37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1939-1676.2011.00776.x","article-title":"Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats","volume":"25","author":"Fox","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.010_bib38","first-page":"S74","article-title":"Cardiac biomarkers in cats","volume":"17","author":"Borgeat","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.010_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1098-612X(03)00007-X","article-title":"Cardiac troponin I in cats with hypertrophic cardiomyopathy","volume":"5","author":"Connolly","year":"2003","journal-title":"J\u00a0Feline Med Surg"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.010_bib40","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1892\/0891-6640(2002)016<0558:CTIIFH>2.3.CO;2","article-title":"Cardiac troponin I in feline hypertrophic cardiomyopathy","volume":"16","author":"Herndon","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jvim.15131","article-title":"Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy","volume":"32","author":"Hori","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/jvim.15498","article-title":"Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats","volume":"33","author":"Hertzsch","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib43","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jvim.12459","article-title":"Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy","volume":"28","author":"Borgeat","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"issue":"14","key":"10.1016\/j.cvsm.2023.05.010_bib44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib45","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1148\/rg.346140030","article-title":"Mapping the future of cardiac MR imaging: case-based review of T1 and T2 mapping techniques","volume":"34","author":"Hamlin","year":"2014","journal-title":"Radiographics"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.010_bib46","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","article-title":"Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"40","author":"Choudhury","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.010_bib47","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib48","first-page":"176","article-title":"Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"29","author":"Wilson","year":"2002","journal-title":"Tex Heart Inst J"},{"issue":"11","key":"10.1016\/j.cvsm.2023.05.010_bib49","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2460\/ajvr.2005.66.1891","article-title":"Comparison of myocardial contrast enhancement via cardiac magnetic resonance imaging in healthy cats and cats with hypertrophic cardiomyopathy","volume":"66","author":"MacDonald","year":"2005","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/rg.291085052","article-title":"A\u00a0pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging","volume":"29","author":"Cummings","year":"2009","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cvsm.2023.05.010_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1532-429X-14-54","article-title":"Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies","volume":"14","author":"Parsai","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcmg.2015.11.005","article-title":"T1 Mapping: Basic Techniques and Clinical Applications","volume":"9","author":"Taylor","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib55","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1148\/radiol.12112721","article-title":"T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy","volume":"265","author":"Sibley","year":"2012","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/CIRCIMAGING.112.976738","article-title":"Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy","volume":"5","author":"Dass","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.010_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","article-title":"Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy","volume":"6","author":"Puntmann","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.cvsm.2023.05.010_bib58","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2016.02.054","article-title":"Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy From Athlete\u2019s Heart","volume":"67","author":"Swoboda","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib59","first-page":"415","article-title":"T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10.1016\/j.cvsm.2023.05.010_bib60","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1532-429X-14-76","article-title":"Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction","volume":"14","author":"Ellims","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"10","key":"10.1016\/j.cvsm.2023.05.010_bib61","first-page":"991","article-title":"CMR-Verified Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HFpEF","volume":"7","author":"Su","year":"2014","journal-title":"JACC (J Am Coll Cardiol): Cardiovascular Imaging"},{"issue":"19","key":"10.1016\/j.cvsm.2023.05.010_bib62","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","article-title":"Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping","volume":"52","author":"Iles","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cvsm.2023.05.010_bib63","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10554-015-0720-0","article-title":"Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis","volume":"31","author":"Nucifora","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.cvsm.2023.05.010_bib64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O\u2019Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.cvsm.2023.05.010_bib65","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10554-016-0958-1","article-title":"Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients","volume":"32","author":"Hu","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.010_bib66","first-page":"344","article-title":"Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function","volume":"16","author":"Yakar T\u00fcl\u00fcce","year":"2016","journal-title":"Anatol J Cardiol"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.010_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"14","key":"10.1016\/j.cvsm.2023.05.010_bib69","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10741-019-09858-2","article-title":"Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis","volume":"25","author":"Chen","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.cvsm.2023.05.010_bib71","first-page":"126","article-title":"Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction","volume":"12","author":"Kanukurti","year":"2020","journal-title":"J\u00a0Lab Physicians"},{"issue":"19","key":"10.1016\/j.cvsm.2023.05.010_bib72","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.cvsm.2023.05.010_bib74","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.cvsm.2023.05.010_bib76","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1439-0442.2003.00546.x","article-title":"Effects of inter- and intra-observer variability on echocardiographic measurements in awake cats","volume":"50","author":"Chetboul","year":"2003","journal-title":"J\u00a0Vet Med A Physiol Pathol Clin Med"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.010_bib77","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.echo.2020.04.009","article-title":"Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance","volume":"33","author":"Urbano-Moral","year":"2020","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib78","first-page":"181","article-title":"Measurement of pulmonary transit time in healthy cats by use of ultrasound contrast media \u201cSonovue\u00ae\u201d: feasibility, reproducibility, and values in 42 cats","volume":"15","author":"Streitberger","year":"2013","journal-title":"J\u00a0Vet Cardiol"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.010_bib79","first-page":"25","article-title":"Increased normalized pulmonary transit times and pulmonary blood volumes in cardiomyopathic cats with or without congestive heart failure","volume":"17","author":"Streitberger","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.010_bib80","article-title":"Ala vestibuloplasty improves cardiopulmonary and activity-related parameters in brachycephalic cats","volume":"7","author":"Gleason","year":"2023","journal-title":"Vet Surg. Published online March"},{"issue":"3","key":"10.1016\/j.cvsm.2023.05.010_bib81","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/jvim.15495","article-title":"Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy","volume":"33","author":"Spalla","year":"2019","journal-title":"J\u00a0Vet Intern Med"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561623000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561623000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:49:26Z","timestamp":1759283366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561623000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0195561623000839"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.010","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophic Cardiomyopathy\u2013Advances in Imaging and Diagnostic Strategies","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}